CytomX Therapeutics
CTMX
$4.43
Share price
-1.56%
Change (1 day)
168.48%
Change (1 year)
Categories
Earnings for CytomX Therapeutics (CTMX)
Earnings in 2023 (TTM): -$6.49 M
According to CytomX Therapeutics 's latest financial reports the company's current earnings (TTM) are -$6.49 M. In 2022 the company made an earning of -$0.13 B a decrease over its 2021 earnings that were of -$83.79 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for CytomX Therapeutics from 2015 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$6.49 M | -94.62% |
| 2022 | -$0.13 B | 43.84% |
| 2021 | -$83.79 M | 72.37% |
| 2020 | -$48.61 M | -52.66% |
| 2019 | -$0.11 B | 31.83% |
| 2018 | -$77.88 M | 68.34% |
| 2017 | -$46.26 M | -20.95% |
| 2016 | -$58.52 M | 73.99% |
| 2015 | -$33.64 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | 1,608.51% | 🇺🇸 USA |